Document Detail

17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism.
MedLine Citation:
PMID:  2153805     Owner:  NLM     Status:  MEDLINE    
We have reported previously that a mixture of conjugated estrogens which is effective in shortening the prolonged bleeding time in uremic patients is also effective on bleeding time in a rat model of uremia. With the present study we took advantage from such a rat model of chronic uremia and decided to identify the component(s) of the conjugated estrogen mixture responsible for shortening the bleeding time. Moreover, we wanted to clarify whether estrogen effect on primary hemostasis is due to a receptor mechanism and can be neutralized by specific estrogen receptor antagonists such as tamoxifen or clomiphene. Both estrone sulfate and 17 beta-estradiol, but not equilin, were effective in shortening the prolonged bleeding time of uremic rats. 17 beta-Estradiol was the most active component of the mixture, reproducing the time course of bleeding time shortening of the entire mixture (effect lasting 48 hr). The effect of estrone sulfate injection lasted only 24 hr. Tamoxifen and clomiphene pretreatment prevented the shortening of bleeding time induced by conjugated estrogen mixture and its active components. These findings indicate that 17 beta-estradiol is the key compound of the conjugated estrogen mixture effective on bleeding time shortening and that the effect of estrogens on primary hemostasis is mediated by a receptor mechanism.
G Viganò; C Zoja; D Corna; M Rossini; F Pusineri; S Garattini; G Remuzzi
Related Documents :
3990315 - Antifertility effect of citrus hystrix dc.
19130315 - Modulatory role of locus coeruleus and estradiol on the stress response of female rats.
6196675 - Anovulation in female rats induced by neonatal administration of the catechol estrogens...
8431995 - Ovarian estrogen acts to feminize the female rat's corpus callosum.
20729265 - Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldos...
11259125 - Therapeutic effects of environmental enrichment on cognitive function and tissue integr...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  252     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-03-12     Completed Date:  1990-03-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  344-8     Citation Subset:  IM    
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clomiphene / pharmacology
Dose-Response Relationship, Drug
Estradiol / pharmacology*
Estrogens, Conjugated (USP) / therapeutic use*
Estrone / pharmacology
Hemorrhage / drug therapy*
Rats, Inbred Strains
Receptors, Estrogen / drug effects*
Tamoxifen / pharmacology
Uremia / complications*
Grant Support
Reg. No./Substance:
0/Estrogens, Conjugated (USP); 0/Receptors, Estrogen; 10540-29-1/Tamoxifen; 50-28-2/Estradiol; 53-16-7/Estrone; 911-45-5/Clomiphene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
Next Document:  Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putati...